ÂÜÀòÂÒÂ×

Pamela Hibler has a diverse work experience spanning over several industries. Their most recent role is as the Director of Sales - West at Clearwave Corporation, a position they have held since 2022. Prior to that, from 2019 to 2022, they served as the President/Owner of Medical Horizons, Inc. where they successfully led the B2B sales and launch of new and disruptive technologies in the medical field.

Before their tenure at Medical Horizons, Inc., Pamela worked as the Senior Vice President, Sales and Distribution, North America at Akers Biosciences, Inc. from 2017 to 2019. From 2013 to 2017, they held two roles at Cogentix Medical, Inc.: first as the Director of Sales - Airway Division, and later as the Director of Sales Operations, Contracts, Training, Clinical Specialists, and Analytics. During this time, they managed and developed teams, implemented a new sales training program, and significantly increased sales and customer reorder rates.

Prior to Cogentix Medical, Pamela was the Western Regional Director at Uroplasty, Inc. from 2010 to 2013. Here, they successfully led and developed teams that significantly increased sales and received various team awards.

Earlier in their career, Pamela served as the President/Owner of Medical Horizons, Inc. from 1998 to 2010, where they achieved sales growth and introduced innovative technologies in the healthcare field.

Before their venture into the medical industry, they worked in sales at US Surgical, where they sold surgical devices and taught physicians new surgical techniques and technologies across various specialties.

Their earlier work experience includes a role as a Ford/Lincoln Mercury Field Sales Manager at Ford Motor Company, where they managed sales and marketing programs for new car dealers and franchises, and successfully launched the Ford Explorer in Northern California.

Pamela Hibler completed their Bachelor of Science in Business Administration degree with a major in Business and a minor in Marketing from Lawrence Technological University in 1989.